Milzer, Marlena
Steindorf, Karen
Reinke, Paul
Schmidt, Martina E.
Funding for this research was provided by:
Deutsches Krebsforschungszentrum (DKFZ)
Article History
Received: 18 May 2022
Accepted: 4 October 2022
First Online: 13 October 2022
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical Faculty of the University of Heidelberg (S-395/2019).
: Informed consent was obtained from all individual participants included in the study.
: N/A
: Marlena Milzer, Paul Reinke, and Martina E Schmidt have no competing interests to declare that are relevant to the content of this article. Karen Steindorf reports personal fees from Adviva Heidelberg, Germany; personal fees from Institut National contre le Cancer (INCA), Paris, France; personal fees from Pierre Fabre, Freiburg, Germany; personal fees and non-financial support from Preventon, Frankfurt, Germany; personal fees from Swiss Group for Clinical Research, Switzerland; personal fees from University of Vienna, Austria; personal fees from Breast Cancer Center Unna, Germany; personal fees and non-financial support from University of Mainz, Germany; personal fees from University of Heidelberg, Germany; and personal fees from Takeda, outside the submitted work.